Good morning, everyone, and how are you today? We are doing just fine, thank you, despite ongoing issues with the Pharmalot heating machine. We choose to take the long view, however, and recall that spring is only a few weeks away. After all, as the Morning Mayor once said: “Every brand new day should be unwrapped like a precious gift.” So while you tug on the ribbon, we will brew another cup of stimulation and forage for interesting items. Speaking of which, here a few to get you started. Hope your day is successful and do keep in touch …

Two young Insys Therapeutics (INSY) salesmen wearing sunglasses and hoodies dance next to a giant spray bottle depicting its Subsys painkiller in a thumping, five-minute rap video made to urge sales reps to get more doctors to prescribe the addictive opioid, The Boston Globe reports (watch here). At one point, a Subsys bottle with a label marked 1,600 micrograms appears in a playground where the salesmen are rapping, and then joins the duo. The refrain in the song, inspired by the rapper A$AP Rocky, is, “I love titration, yeah that’s not a problem. I got new patients, and I got a lot of ’em.”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy